<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title> &#187; Virus</title>
	<atom:link href="http://pharmaexecnews.com/category/pharmaceuticals/virus-pharmaceuticals/feed/" rel="self" type="application/rss+xml" />
	<link>http://pharmaexecnews.com</link>
	<description></description>
	<lastBuildDate>Fri, 29 Apr 2011 14:00:12 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Low Sunlight Exposure and Common Virus Responsible for Multiple Sclerosis</title>
		<link>http://pharmaexecnews.com/biotechnology/biomedical/sunlight-exposure-common-virus-responsible-multiple-sclerosis/</link>
		<comments>http://pharmaexecnews.com/biotechnology/biomedical/sunlight-exposure-common-virus-responsible-multiple-sclerosis/#comments</comments>
		<pubDate>Tue, 26 Apr 2011 14:00:15 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Virus]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11514</guid>
		<description><![CDATA[New research has indicated that people who are exposed to very low levels of sunlight and who also have a history of having a common virus known as mononucleosis, are at greater odds of developing multiple sclerosis (MS) than those without the virus.

According to George C. Ebers, MD, with the University of Oxford in the [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/biomedical/sunlight-exposure-common-virus-responsible-multiple-sclerosis/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>India Agrees to Check for Superbug</title>
		<link>http://pharmaexecnews.com/biotechnology/india-agrees-check-superbug/</link>
		<comments>http://pharmaexecnews.com/biotechnology/india-agrees-check-superbug/#comments</comments>
		<pubDate>Mon, 18 Apr 2011 14:00:14 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Virus]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11465</guid>
		<description><![CDATA[After many days of openly denying the &#8220;existence and public health importance&#8221; of the NDM-1 gene, India has finally agreed to search for the presence of superbugs in the Capital and its water supply lines.Quietly yielding under pressure, the National Centre for Disease Control (NCDC) has agreed to lead a study to detect the &#8220;prevalence [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/india-agrees-check-superbug/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Possible Breakthrough in Battle against AIDS: Protein Fragment Blocks AIDS Virus Entry into Cells</title>
		<link>http://pharmaexecnews.com/biotechnology/breakthrough-battle-aids-protein-fragment-blocks-aids-virus-entry-cells/</link>
		<comments>http://pharmaexecnews.com/biotechnology/breakthrough-battle-aids-protein-fragment-blocks-aids-virus-entry-cells/#comments</comments>
		<pubDate>Thu, 14 Apr 2011 08:00:24 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Immune Disorders]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Proteomics]]></category>
		<category><![CDATA[Virus]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11442</guid>
		<description><![CDATA[Researchers worldwide are hailing a new discovery as being a possible breakthrough in the treatment for AIDS. Scientists have developed a new protein that stops the AIDS the virus from entering cells. This protein has a basic make-up of naturally occurring proteins in the body that protects cells from viruses, except the human-made version does [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/breakthrough-battle-aids-protein-fragment-blocks-aids-virus-entry-cells/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Nanoparticles from MIT could lead to Vaccines for HIV, Malaria and Others</title>
		<link>http://pharmaexecnews.com/pharmaceuticals/drug-discovery/nanoparticles-mit-lead-vaccines-hiv-malaria/</link>
		<comments>http://pharmaexecnews.com/pharmaceuticals/drug-discovery/nanoparticles-mit-lead-vaccines-hiv-malaria/#comments</comments>
		<pubDate>Fri, 11 Mar 2011 08:00:16 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Disease]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[Immune Disorders]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Nanotechnology]]></category>
		<category><![CDATA[Virus]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[nano]]></category>
		<category><![CDATA[nanobiotechnology]]></category>
		<category><![CDATA[nanotechnology]]></category>
		<category><![CDATA[Nanotechnology - Revolutionizing R&D to Develop Smarter Therapeutics and Diagnostics]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11275</guid>
		<description><![CDATA[While it might seem unbelievable, MIT engineers have announced that they have managed to design a new type of nanoparticles that could effectively and safely deliver vaccines for diseases such as malaria and HIV. HIV is known to be one of the biggest killers in the world and till now no one has been able [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/pharmaceuticals/drug-discovery/nanoparticles-mit-lead-vaccines-hiv-malaria/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Bacteria Provide Example of One of Nature&#8217;s First Immune Systems</title>
		<link>http://pharmaexecnews.com/biotechnology/bacteria-provide-natures-immune-systems/</link>
		<comments>http://pharmaexecnews.com/biotechnology/bacteria-provide-natures-immune-systems/#comments</comments>
		<pubDate>Tue, 04 Jan 2011 08:00:39 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[General News]]></category>
		<category><![CDATA[Genomics]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[Virus]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[dna]]></category>
		<category><![CDATA[dna sequence]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11038</guid>
		<description><![CDATA[Studying how bacteria incorporate foreign DNA from invading viruses into their own regulatory processes, Thomas Wood, professor in the Artie McFerrin Department of Chemical Engineering at Texas  A&#38;M University, is uncovering the secrets of one of nature&#8217;s most primitive immune systems.

His findings, which appear in Nature Communications, shed light on how bacteria have throughout [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/bacteria-provide-natures-immune-systems/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>H1N1 Vaccine Linked to 700% Increase in Miscarriages?</title>
		<link>http://pharmaexecnews.com/biotechnology/h1n1-vaccine-linked-700-increase-miscarriages/</link>
		<comments>http://pharmaexecnews.com/biotechnology/h1n1-vaccine-linked-700-increase-miscarriages/#comments</comments>
		<pubDate>Mon, 13 Dec 2010 08:00:40 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[Virus]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[pharmaceutical companies]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10966</guid>
		<description><![CDATA[Recent data presented to the U.S. Centers for Disease Control and Prevention&#8217;s (CDC) Advisory Committee on Children&#8217;s Vaccines has revealed some shocking information about the effects of the H1N1 / swine flu vaccine on pregnant women. According to the National Coalition of Organized Women, the rate of miscarriage among pregnant women during the 2009 H1N1 [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/h1n1-vaccine-linked-700-increase-miscarriages/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HIV Virus Hides in the Brain, Swedish Study Finds</title>
		<link>http://pharmaexecnews.com/biotechnology/hiv-virus-hides-brain-swedish-study-finds/</link>
		<comments>http://pharmaexecnews.com/biotechnology/hiv-virus-hides-brain-swedish-study-finds/#comments</comments>
		<pubDate>Wed, 22 Sep 2010 08:00:44 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Immune Disorders]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[International News]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Virus]]></category>
		<category><![CDATA[adenoviruses]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[Bioinformatics Market Potential]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10725</guid>
		<description><![CDATA[Studies of the spinal fluid of patients given anti-HIV drugs have resulted in new findings suggesting that the brain can act as a hiding place for the HIV virus. Around 10% of patients showed traces of the virus in their spinal fluid but not in their blood &#8212; a larger proportion than previously realized, reveals [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/hiv-virus-hides-brain-swedish-study-finds/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Four Drugs Look to Pass FDA Muster this Month</title>
		<link>http://pharmaexecnews.com/biotechnology/drugs-pass-fda-muster-month/</link>
		<comments>http://pharmaexecnews.com/biotechnology/drugs-pass-fda-muster-month/#comments</comments>
		<pubDate>Fri, 17 Sep 2010 08:00:01 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Companies]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[General News]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Medical Patents]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[New Drugs]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Regulatory]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[Virus]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10711</guid>
		<description><![CDATA[Brian Orelli of The Motley Fool highlights four drugs&#8211;AstraZeneca&#8217;s Brilinta, Questcor&#8217;s Acthar Gel, Savient&#8217;s Krystexxa and Novartis&#8217; Gilenia&#8211;that could gain FDA approval this month despite some previous difficulties. However, given recent troubles with other approved drugs, the FDA&#8217;s cautious nature could cause issues for some of the drugmakers.

Back in July, Brilinta received a 7-to-1 FDA [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/drugs-pass-fda-muster-month/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Nearly 400 Medicines and Vaccines in Development to Fight Infectious Diseases</title>
		<link>http://pharmaexecnews.com/biotechnology/400-medicines-vaccines-development-fight-infectious-diseases/</link>
		<comments>http://pharmaexecnews.com/biotechnology/400-medicines-vaccines-development-fight-infectious-diseases/#comments</comments>
		<pubDate>Tue, 14 Sep 2010 08:00:13 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[Immune Disorders]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Medical Patents]]></category>
		<category><![CDATA[New Drugs]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Regulatory]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[Virus]]></category>
		<category><![CDATA[Bioinformatics Market Potential]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10699</guid>
		<description><![CDATA[Critical challenges remain in the centuries-old battles against infectious diseases, particularly as bacteria and viruses mutate and as the threat of bioterrorism grows. Responding to this need, America&#8217;s biopharmaceutical research companies this year have 395 new medicines and vaccines in the pipeline to fight infectious diseases. All 395 are in later stages of development, meaning [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/400-medicines-vaccines-development-fight-infectious-diseases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Feds Aim to Fortify Biodefense by Fixing Product Development Pipeline</title>
		<link>http://pharmaexecnews.com/biotechnology/feds-aim-fortify-biodefense-fixing-product-development-pipeline/</link>
		<comments>http://pharmaexecnews.com/biotechnology/feds-aim-fortify-biodefense-fixing-product-development-pipeline/#comments</comments>
		<pubDate>Mon, 30 Aug 2010 08:00:09 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Drug Delivery]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[General News]]></category>
		<category><![CDATA[Government Policy]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[New Drugs]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[Virus]]></category>
		<category><![CDATA[biochip]]></category>
		<category><![CDATA[biochips]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[Bioinformatics Market Potential]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[molecular biology]]></category>
		<category><![CDATA[nanobiotechnology]]></category>
		<category><![CDATA[Nanotechnology - Revolutionizing R&D to Develop Smarter Therapeutics and Diagnostics]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Strategic Alliances in World Pharma and Biotech Markets]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10659</guid>
		<description><![CDATA[A leaky product development pipeline is hampering the country&#8217;s ability to ensure a steady output of new medical countermeasures, such as medications, vaccines, equipment and supplies needed for health emergencies, HHS Secretary Kathleen Sebelius said.

She spoke at the unveiling of a report that reviewed the federal government&#8217;s system for producing medical countermeasures and recommended fixes [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/feds-aim-fortify-biodefense-fixing-product-development-pipeline/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

